Why Some People Using Automated Insulin Delivery Still Struggle With Blood Sugar Control

Researchers looked at 23 adults with Type 1 diabetes who were using automated insulin delivery systems—devices that automatically adjust insulin doses throughout the day. They collected information about when people were diagnosed, how long they'd been using their AID system, and their blood sugar control measured by HbA1c levels.

The results were sobering: more than three out of four participants (78.3%) had blood sugar levels that fell short of the American Diabetes Association's recommended target of below 7%. The average HbA1c among the group was 8.0%, indicating room for improvement.

The study identified one factor that stood out as significant: when someone was first diagnosed with Type 1 diabetes. People who were diagnosed at an older age tended to have better blood sugar control while using their AID systems, compared to those diagnosed in childhood.

This finding was strong enough that researchers identified age at diagnosis as the main independent predictor of who would struggle with glycemic control. The reasons behind this pattern weren't explored in this study, but it suggests that factors related to earlier diagnosis—whether biological, developmental, or related to disease management—may influence how well insulin delivery systems work over time.

Another interesting finding emerged around how long people had been using their AID systems. Those who had used the technology for 6 to 12 months showed better blood sugar control than those with either shorter or longer periods of use. This suggests there may be an optimal window where people are getting the most benefit from their device, though the study doesn't explain why this pattern exists.

It's worth noting that this was a small study of 23 patients, mostly women with an average age of about 24 years. These findings offer clues rather than definitive answers, and more research with larger groups would help clarify which factors truly influence AID outcomes.

Automated insulin delivery systems are powerful tools, but this research confirms what many in the Type 1 diabetes community already know: technology alone isn't a complete solution. Even with an advanced device doing much of the heavy lifting, achieving target blood sugar levels remains a challenge for most people.

The finding that age at diagnosis plays a role doesn't change anyone's management—it simply highlights that people diagnosed earlier may need extra attention and support to reach their glycemic targets. If you're using an AID system and not hitting your goals, that's a signal to connect with your diabetes care team about what adjustments might help, whether related to settings, lifestyle factors, or additional support resources.

Source: Acta endocrinologica (Bucharest, Romania : 2005). Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.